- Home
- PHAR vs CRML Comparison
PHAR vs CRML Comparison
Compare PHAR & CRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- CRML
- Stock Information
- Founded
- PHAR 1988
- CRML N/A
- Country
- PHAR Netherlands
- CRML United States
- Employees
- PHAR N/A
- CRML N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- CRML
- Sector
- PHAR Health Care
- CRML
- Exchange
- PHAR Nasdaq
- CRML NYSE
- Market Cap
- PHAR 627.5M
- CRML 604.3M
- IPO Year
- PHAR N/A
- CRML N/A
- Fundamental
- Price
- PHAR $9.98
- CRML $8.60
- Analyst Decision
- PHAR Strong Buy
- CRML
- Analyst Count
- PHAR 3
- CRML 0
- Target Price
- PHAR $27.00
- CRML N/A
- AVG Volume (30 Days)
- PHAR 5.6K
- CRML 69.3K
- Earning Date
- PHAR 03-13-2025
- CRML 02-01-2025
- Dividend Yield
- PHAR N/A
- CRML N/A
- EPS Growth
- PHAR N/A
- CRML N/A
- EPS
- PHAR N/A
- CRML N/A
- Revenue
- PHAR $285,745,000.00
- CRML $117,660.00
- Revenue This Year
- PHAR $20.08
- CRML N/A
- Revenue Next Year
- PHAR $9.22
- CRML N/A
- P/E Ratio
- PHAR N/A
- CRML N/A
- Revenue Growth
- PHAR 30.64
- CRML 5.79
- 52 Week Low
- PHAR $6.65
- CRML $5.32
- 52 Week High
- PHAR $13.20
- CRML $22.50
- Technical
- Relative Strength Index (RSI)
- PHAR 56.13
- CRML 60.58
- Support Level
- PHAR $9.37
- CRML $7.29
- Resistance Level
- PHAR $10.15
- CRML $9.89
- Average True Range (ATR)
- PHAR 0.50
- CRML 0.76
- MACD
- PHAR -0.09
- CRML 0.12
- Stochastic Oscillator
- PHAR 57.53
- CRML 44.25
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About CRML CRITICAL METALS CORPORATION
Critical Metals Corp is engaged in lithium exploration in Austria. It is focused on the development of its wholly-owned Wolfsberg Lithium Project (the Wolfsberg Project) located in Carinthia, Austria.